Great Point Partners as of June 30, 2022
Portfolio Holdings for Great Point Partners
Great Point Partners holds 34 positions in its portfolio as reported in the June 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Xenon Pharmaceuticals (XENE) | 8.1 | $34M | 1.1M | 30.42 | |
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 7.1 | $30M | 190k | 156.01 | |
| Karuna Therapeutics Ord Put Option | 6.2 | $26M | 204k | 126.50 | |
| Cytokinetics Com New (CYTK) | 5.7 | $24M | 610k | 39.29 | |
| Travere Therapeutics (TVTX) | 5.6 | $24M | 971k | 24.23 | |
| Alnylam Pharmaceuticals Put Option (ALNY) | 5.2 | $22M | 150k | 145.85 | |
| Vaxcyte (PCVX) | 5.1 | $21M | 985k | 21.76 | |
| Galapagos Nv Spon Adr (GLPG) | 4.8 | $20M | 360k | 55.80 | |
| Point Biopharma Global | 4.0 | $17M | 2.4M | 6.81 | |
| Aclaris Therapeutics (ACRS) | 3.6 | $15M | 1.1M | 13.96 | |
| Kalvista Pharmaceuticals (KALV) | 3.6 | $15M | 1.5M | 9.84 | |
| Sarepta Therapeutics (SRPT) | 3.5 | $15M | 194k | 74.96 | |
| Relmada Therapeutics (RLMD) | 3.2 | $13M | 700k | 18.99 | |
| Cincor Pharma | 3.0 | $13M | 669k | 18.84 | |
| Nektar Therapeutics (NKTR) | 2.9 | $12M | 3.2M | 3.80 | |
| Kiniksa Pharmaceuticals Com Cl A (KNSA) | 2.8 | $12M | 1.2M | 9.69 | |
| Tricida | 2.7 | $11M | 1.2M | 9.68 | |
| Alkermes SHS (ALKS) | 2.6 | $11M | 362k | 29.79 | |
| Precision Biosciences Ord | 2.2 | $9.2M | 5.8M | 1.60 | |
| Anaptysbio Inc Common (ANAB) | 2.2 | $9.2M | 453k | 20.30 | |
| Neurocrine Biosciences (NBIX) | 1.8 | $7.3M | 75k | 97.48 | |
| Avidity Biosciences Ord (RNA) | 1.7 | $7.3M | 500k | 14.53 | |
| Urogen Pharma (URGN) | 1.7 | $7.2M | 873k | 8.19 | |
| Acumen Pharmaceuticals (ABOS) | 1.7 | $7.1M | 1.5M | 4.70 | |
| Chinook Therapeutics | 1.4 | $5.9M | 337k | 17.49 | |
| Ventyx Biosciences (VTYX) | 1.1 | $4.8M | 389k | 12.23 | |
| Silence Therapeutics Ads (SLN) | 1.1 | $4.8M | 401k | 11.85 | |
| Pieris Pharmaceuticals (PIRS) | 1.1 | $4.7M | 2.5M | 1.87 | |
| Alpine Immune Sciences (ALPN) | 1.1 | $4.6M | 539k | 8.51 | |
| 89bio (ETNB) | 1.1 | $4.5M | 1.4M | 3.22 | |
| Pliant Therapeutics (PLRX) | 0.7 | $2.9M | 357k | 8.01 | |
| Moonlake Immunotherapeutics Class A Ord (MLTX) | 0.5 | $2.3M | 432k | 5.25 | |
| Magenta Therapeutics | 0.3 | $1.4M | 1.2M | 1.20 | |
| Aeglea Biotherapeutics | 0.3 | $1.3M | 2.5M | 0.51 |
